ARZB-001

N/A

Report date: 2025/01/26 15:02:12
NME

Base Information

Drug NameARZB-001
Drug Alias NameARZB-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArtizan Biosciences Inc
China Registration ClassN/A

Develop Information

Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A